Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-10-24
2009-02-17
Desai, Rita J (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S207000, C546S208000, C546S209000, C546S210000, C546S211000
Reexamination Certificate
active
07491737
ABSTRACT:
The present invention is directed to compounds of the formula (I): (wherein R1, R2, R3, R4, R5, R6, R10and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.
REFERENCES:
patent: 5843966 (1998-12-01), Armou et al.
patent: 6140338 (2000-10-01), Naya et al.
patent: 6248755 (2001-06-01), Chapman et al.
patent: 6498161 (2002-12-01), Caldwell et al.
patent: 6531484 (2003-03-01), Willoughby et al.
patent: 2005/0250814 (2005-11-01), Zhou et al.
patent: 2005/0261325 (2005-11-01), Butora et al.
patent: 2006/0116421 (2006-06-01), Butora et al.
patent: 2006/0173013 (2006-08-01), Zhou et al.
patent: WO 02/13824 (2002-01-01), None
patent: WO/0213824 (2002-02-01), None
patent: WO 2004/110376 (2004-12-01), None
Xia et. al. “Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists” Bioorganic & Medicinal Chemistry Letters 2007; 17, 5964-5968.
Anthony B. Pinkerton “Diaryl substituted pyrazoles as potent CCR2 receptor antagonists” Bioorganic & Medicinal Chemistry Letters 2007, 17, 807-813.
Yang et. al. “Discovery of 3,5-bis(trifluoromethyl)benzyl L-arylglycinamide based potent CCR2 antagonists” Bioorganic & Medicinal Chemistry Letters 2006, 16, 3735-3739.
Pozharskii et. al. Heterocycles in Life and Society Wiley, 1997, pp. 1-6.
Goble Stephen D.
Pasternak Alexander
Yang Lihu
Daniel Mark
Desai Rita J
McGinnis James L.
Merck & Co. , Inc.
O'Dell David K
LandOfFree
Heterarylpiperidine modulators of chemokine receptor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterarylpiperidine modulators of chemokine receptor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterarylpiperidine modulators of chemokine receptor activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4106608